Search
for

    Sort by

    Research 30 of 1000+

    1. Drug repositioning using <i>in silico</i> compound profiling Future Medicinal Chemistry · 2009 · 24 citations
    2. THE IDENTIFICATION OF MOLECULAR MECHANISMS FROM BIOACTIVE COMPOUNDS IN Sansevieria trifasciata PLANT AS ANTI-ALOPECIA: In-Silico APPROACH Rasayan journal of Chemistry · 2022 · 2 citations
    3. ANTIALOPECIA ACTIVITY EXPLORATION BY In-silico ANALYSIS OF BIOACTIVE COMPOUNDS FROM Sansevieria trifasciata PRAIN LEAVES THROUGH 5α-REDUCTASE INHIBITION 2023
    4. Pharmacological Effects of Natural Compounds Extracted from Urtica dioica Evaluated by in Silico and Experimental Methods Revista de Chimie · 2018 · 3 citations
    5. Identification and in silico analysis of phytochemicals from Phyla nodiflora (l.): Potential bioactive compounds for targeted therapy 2024
    6. Natural Product-InspiredBis(trifluoromethyl) PhenylHydroxycinnamate Derivatives as Promising Nonsteroidal Inhibitorsof Human Steroid 5α-Reductase Type-1: Synthesis, <i>InVitro</i>, and <i>In Silico</i> Studies OPAL (Open@LaTrobe) (La Trobe University) · 2025
    7. Natural Product-Inspired Bis(trifluoromethyl) Phenyl Hydroxycinnamate Derivatives as Promising Nonsteroidal Inhibitors of Human Steroid 5α-Reductase Type-1: Synthesis, <i>In Vitro</i>, and <i>In Silico</i> Studies ACS Omega · 2025
    8. Virtual Screening of Compounds in Candlenut and Aloe Vera against Androgen Receptor (PDB ID:4K7A) for Anti-Hair Loss Research Journal of Pharmacy and Technology · 2026
    9. In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling Zenodo (CERN European Organization for Nuclear Research) · 2026
    10. In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling Zenodo (CERN European Organization for Nuclear Research) · 2026
    11. IN SILICO STUDY OF 12 PHYTOSTEROL COMPOUNDS IN MORINGA (MORINGA OLEIFERA LAMK.) SEED OIL ON 5Α-REDUCTASE ENZYME INHIBITION ACTIVITY AS ANTI-ALOPECIA International Journal of Applied Pharmaceutics · 2022
    12. In Silico Screening of DrugBank Compounds as Potential Inhibitors for Human Steroid 5α-Reductase 2 for Androgen-Related Diseases Biointerface Research in Applied Chemistry · 2023
    13. Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight Biomolecules · 2022 · 21 citations
    14. Development and Evaluation of a Herbal Hair Serum Containing Tridax procumbens: An In Silico and Phyto pharmacological Study Future Journal of Pharmaceuticals and Health Sciences · 2026
    15. Chemical Profiling, Pharmacological Insights and In Silico Studies of Methanol Seed Extract of Sterculia foetida Plants · 2021 · 22 citations
    16. Phytochemical Profiling, Antioxidant Activity, and In Silico Analyses of Sterculia villosa and Vernonia patula Evidence-based Complementary and Alternative Medicine · 2022 · 16 citations
    17. A REVIEW OF THE PHYTOCHEMISTRY AND FORMULATION ASPECTS OF EQUISETUM ARVENSE EXTRACT IN COSMETIC APPLICATIONS Zenodo (CERN European Organization for Nuclear Research) · 2026
    18. Ficus benghalensis as Potential Inhibitor of 5α-Reductase for Hair Growth Promotion: In Vitro, In Silico, and In Vivo Evaluation Frontiers in Pharmacology · 2021 · 3 citations
    19. In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss Journal of Ethnopharmacology · 2015 · 30 citations
    20. Mechanotransduction in Androgenetic Alopecia: An In Silico Repositioning Study of PIEZO1 + MLCK Axis Using Cofolding and Pilosebaceous Single-Cell Atlas Constraints Zenodo (CERN European Organization for Nuclear Research) · 2026
    21. Multi-target evaluation of Korean herbal compounds against the SRD5A2 / AR / beta-catenin axis for androgenetic alopecia: Boltz-2 cofold, ChEMBL-anchored ranking, ADMET-AI 107-endpoint safety panel, and pilosebaceous single-cell atlas-constrained prioritization of Saponin Re, Emodin, and Biochanin A Open Science Framework · 2026
    22. Multi-target evaluation of Korean herbal compounds against the SRD5A2 / AR / beta-catenin axis for androgenetic alopecia: Boltz-2 cofold, ChEMBL-anchored ranking, ADMET-AI 107-endpoint safety panel, and pilosebaceous single-cell atlas-constrained prioritization of Saponin Re, Emodin, and Biochanin A Zenodo (CERN European Organization for Nuclear Research) · 2026
    23. Mechanotransduction in Androgenetic Alopecia: An *In Silico* Repositioning Study of PIEZO1 + MLCK Axis Using Cofolding and Pilosebaceous Single-Cell Atlas Constraints Open MIND · 2026
    24. <i>In Vitro</i> Antibacterial and Antioxidant Activities, Pharmacokinetics, and <i>In Silico</i> Molecular Docking Study of Phytochemicals from the Roots of <i>Ziziphus spina-christi</i> Biochemistry Research International · 2024
    25. Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques Scientific African · 2024
    26. Computational drug discovery of potential 5α-reductase phytochemical inhibitors and hair growth promotion using in silico techniques Frontiers in Bioinformatics · 2025
    27. In Silico Prediction of Metabolite in Petroselinum Crispum in Inhibiting Androgen Receptor as Treatment for Alopecia Research journal of pharmacy and technology · 2022 · 3 citations
    28. A REVIEW OF THE PHYTOCHEMISTRY AND FORMULATION ASPECTS OF EQUISETUM ARVENSE EXTRACT IN COSMETIC APPLICATIONS Zenodo (CERN European Organization for Nuclear Research) · 2026
    29. Mechanotransduction in Androgenetic Alopecia: An In Silico Repositioning Study of PIEZO1 + MLCK Axis Using Cofolding and Pilosebaceous Single-Cell Atlas Constraints Zenodo (CERN European Organization for Nuclear Research) · 2026
    30. Mechanotransduction in Androgenetic Alopecia: An In Silico Repositioning Study of PIEZO1 + MLCK Axis Using Cofolding and Pilosebaceous Single-Cell Atlas Constraints Zenodo (CERN European Organization for Nuclear Research) · 2026